Autolus Therapeutics plc Quarterly Entity Common Stock, Shares Outstanding from Q3 2018 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Autolus Therapeutics plc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2018 to Q3 2024.
  • Autolus Therapeutics plc Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 266M shares, a 53% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 266M +92.1M +53% Nov 8, 2024 10-Q 2024-11-12
Q2 2024 266M Aug 6, 2024 10-Q 2024-08-08
Q1 2024 266M Mar 20, 2024 10-K 2024-03-21
Q3 2023 174M Nov 9, 2023 10-Q 2023-11-09
Q4 2022 173M +82.2M +90.4% Dec 31, 2022 20-F 2023-03-07
Q4 2021 90.9M +38.6M +73.7% Dec 31, 2021 20-F 2022-03-10
Q4 2020 52.3M +7.36M +16.4% Dec 31, 2020 20-F 2021-03-04
Q4 2019 45M +4.84M +12.1% Dec 31, 2019 20-F 2020-03-03
Q4 2018 40.1M Dec 31, 2018 20-F 2019-02-25
Q3 2018 40.1M Sep 30, 2018 20-F 2018-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.